NCT00418158

Brief Summary

Abstract: Post-operative pulmonary complications after cardiac surgery Background The Catharina Hospital performs approximately 1700 heart operation each year. One third of the patients stay at the Catharina hospital during their entire post-operative period. Two years ago they abolished the pulmonary support by a physiotherapist. Subjectively, the pulmonary complications increased over the last two years. During an investigation of the contentment of the patients an increase of the pulmonary problems came forward after eliminating the pulmonary support. There have been no further examinations to the pulmonary complications post-operatively. Objectives The aim of this study is to give the department of cardio-thoracic surgery an advice about the post-operative pulmonary support for patients who underwent heart surgery. During the study a budgetary analysis will be made. Methods 120 patients are prospectively randomised in three groups. Randomisation takes place through block randomisation every three weeks. 40 patients will be supported by a physiotherapist. Another 40 patients will be supported by the nurses on the cardiothoracic surgery ward and the last 40 patients will use an incentive therapy with 'Airlife' by a self-management method. The study population are all patients undergoing heart surgery and spend their entire post-operative period at the Catharina Hospital. In- and exclusion criteria are specified in the protocol on pages 3 and 4. Outcome The primary outcome is to qualify the pulmonary complications within the three groups. These complications will be objectified by measuring peak flow, an instrument to determine the lung function, and an x-ray of the thorax. The secondary outcome is the contentment of the patient, which will be determined by a VAS-score (Visual Analogue Scale). Risks There are no risks for the patient when participating on this study. The patient will have to fill in the VAS-score and measure lung function with the peak flow at two different moments. The study takes place in a clinical setting. There is no extra insurance in conformity with the advice of the METC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2005

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 4, 2007

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

November 10, 2009

Status Verified

November 1, 2009

Enrollment Period

2.1 years

First QC Date

January 3, 2007

Last Update Submit

November 9, 2009

Conditions

Keywords

Pulmonary complications

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Euroscore \< 8
  • Age \> 18 year
  • Patients whereby ECC is peri-operatively used
  • No psychological history
  • Informed consent obtained
  • Follow -up at Catherina Hospital

You may not qualify if:

  • COPD
  • Mitral valve plasty or reconstruction
  • Off-pump
  • Cognitive problems
  • Expected comlpications during operation
  • Patients with decompensation
  • Day 5 post- ok thoracic drains insitu
  • Pain score grater than 4
  • Abnormal chest x-ray

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina Hospital

Eindhoven, 5623 EJ, Netherlands

Location

MeSH Terms

Interventions

Therapeutics

Study Officials

  • F.J. ter Woorst, MD

    Catharina Hospital Eindhoven, department of CardioThoracic Surgery. The Netherlands

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 3, 2007

First Posted

January 4, 2007

Study Start

December 1, 2005

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

November 10, 2009

Record last verified: 2009-11

Locations